Story
Nemera Owners Explore Sale at Potential €3 Billion Valuation Amid GLP-1 Boom
Private equity firms Astorg Partners and Montagu Private Equity are exploring a sale of their majority stake in Nemera, a French manufacturer of drug delivery devices, according to a Bloomberg report citing people familiar with the matter. The potential sale is being driven by surging demand for devices used with popular GLP-1 weight-loss medications.
Potential Deal Structure
The owners are in discussions with advisers regarding a potential sale that could value Nemera at approximately €3 billion ($3.5 billion), the sources said. The process is reportedly in its early stages and is expected to officially commence in the coming months.
This move follows a transaction last year in which Astorg and Montagu brought in LGT Capital Partners as a minority shareholder in the company.
The GLP-1 Catalyst
AdThe exploration of a sale comes as the market for GLP-1 agonists, used in blockbuster diabetes and weight-loss drugs, has created a significant demand surge for the specialized devices needed to administer them. Nemera is a key supplier in this ecosystem, manufacturing products essential for these therapies.
Nemera specializes in a range of drug delivery systems, including:
- Auto-injectors
- Pens
- Inhalers
- Pumps and eye droppers
The company is actively expanding its manufacturing capacity to meet the growing demand for devices compatible with GLP-1 drugs and insulin therapies. Nemera operates manufacturing facilities in the US, France, Germany, Poland, and Brazil.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.